Overview

Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy

Status:
Unknown status
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The study aimed to assess the effectiveness and safety of L-ornithine-L-aspartate in the management of hepatic encephalopathy.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Treatments:
N-Methylaspartate